Gossamer Bio Inc. (GOSS) Tops Q1 EPS by 3c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $9.89 million versus the consensus estimate of $4.25 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Virtu Financial posts Q2 2026 preliminary results, seeks $400M loan
• Wolfe Research on Goldman Sachs (GS): 'we expect shares to outperform in today’s session'
• Goldman Sachs on Bank of America (BAC): 'We view these results as better than expected'